India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...

While HDFC Securities has assigned a 'Buy' rating to Divi's Labs, Sai Life Sciences, and Piramal Pharma, it has given an 'Add ...

Jefferies' top picks in the CRDMO space are Sai Lifesciences and Divi’s for strong execution and healthy growth outlook.

LOLC Divi Saviya successfully concluded the first phase of ‘Obai, Mamai, Ape Ratai,’ making a significant impact on Sri Lanka ...

It’s only been a few days since the start of 2026, but global equity markets are already reaching new all-time highs. One key ...

Wix holds the top spot in 2026, thanks to its combination of extensive business tools, powerful AI-features, super-easy-to-use interface, and responsive, professional support. Of course, the best ...

QDTE's daily covered call strategy on Nasdaq 100 delivers high yields and income, but requires caution due to payout ...

Indian equities recovered from intraday lows to end near flat. The Sensex slipped 102 points to close at 84,961, while the ...

Nirmala Sitharaman will break her own record and become the first Indian Finance Minister to present the Budget for the nine ...

President Donald Trump's Assistant Attorney General for Civil Rights, Harmeet Dhillon, is facing a staffing crisis as not ...

Shares of Divi's Laboratories Ltd. gained nearly 2% on Tuesday, January 6, as brokerage firm Citi said it is positive on the stock. Citi maintained its "buy" rating on Divi's Laboratories with a price ...